Amphastar Pharmaceuticals, Inc. (AMPH) Gross margin 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) gross margin by fiscal year — reported gross profit divided by reported revenue.
49.5%FY2025 · since FY2016: 40.8% → 49.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 49.5% | -1.6 pp |
| FY2024 | 51.1% | -3.4 pp |
| FY2023 | 54.5% | +4.6 pp |
| FY2022 | 49.9% | +4.2 pp |
| FY2021 | 45.6% | +4.7 pp |
| FY2020 | 41.0% | +0.0 pp |
| FY2019 | 40.9% | +4.6 pp |
| FY2018 | 36.3% | -1.4 pp |
| FY2017 | 37.7% | -3.2 pp |
| FY2016 | 40.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice